ICH E6(R3) Annex 2: What the New GCP Rules for Decentralised and Platform Trials Mean for APAC Sponsors
ICH E6(R3) was adopted in 2023 as the first full revision of the GCP guideline in over two decades. The core document introduced risk-based quality management as a foundational principle. It also restructured sponsor oversight obligations and modernised the framework for data integrity and quality tolerance limits. Importantly, that core text applies to all interventional […]
Read More →